Low tumor interleukin-1ß expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study S. Safi; J. Krzykalla; H. Hoffmann; A. Benner; H. Bischoff; M. Eichhorn; M. Kriegsmann; I. Poschke; F. Stögbauer; L. Umansky; C. Mogler; W. Weichert; H. Winter; P. Beckhove; T. Muley;

Recommendations for the implementation of a national lung cancer screening program in Portugal¿A consensus statement M.G.O. Fernandes; M. Dias; R. Santos; S. Ravara; P. Fernandes; J. Firmino-Machado; J.P. Antunes; O. Fernandes; A. Madureira; V. Hespanhol; C. Rodrigues; C.A. Vicente; S. Alves; G. Mendes; R. Ilgenfritz; B.S. Pinto; J. Alves; I. Saraiva; C. Bárbara; M.A. Cipriano; A. Figueiredo; M.S. Uva; N. Jacinto; L. Curvo-Semedo; A. Morais;

Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib O.F. Olmez; A. Bilici; P. Gursoy; E. Cubukcu; A. Sakin; T. Korkmaz; I. Cil; B. Cakar; S. Menekse; T. Demir; O. Acikgoz; J. Hamdard;